AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18713312
Drug: Acid infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acid infusion aspirated 3 cm distally
Trial: 16710092
Drug: Remifentanil (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (0.25 microg.kg(‐1) continuous infusion)
Trial: 12456442
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (0.6 mg) combined with epidural neostigmine (60 micro g)
Trial: 12456442
Drug: Epidural neostigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural neostigmine (60 micro g)
Trial: 12456442
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (0.6 mg)
Trial: 2024911
Drug: Enalapril/Hydrochlorothiazide (E/HCTZ:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril/Hydrochlorothiazide (E/HCTZ: 20/12.5-40/25 mg)
Trial: 2024911
Drug: Enalapril (E:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (E: 20-40 mg)
Trial: 2024911
Drug: Hydrochlorothiazide (HCTZ:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ: 12.5-25 mg)
Trial: 7282909
Drug: Preventive antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive antibiotic treatment with clindamycin and gentamycin
Trial: 6356004
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic therapy
Trial: 6421007
Drug: ISDN (Isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISDN (Isosorbide dinitrate) - mean dose 15.5 micrograms kg‐1 min‐1
Trial: 6421007
Drug: NTG (Nitroglycerin)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NTG (Nitroglycerin) - mean dose 5.5 micrograms kg‐1 min‐1
Trial: 29924642
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg every 8 hours
Trial: 26414108
Drug: Triple antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antiplatelet therapy (TAPT) - aspirin plus clopidogrel plus cilostazol (100 mg loading, followed with 50 mg twice per day) for 3-6 months
Trial: 6806218
Drug: 200 rad
RxNorm normalized name: RAD-IFN
DrugBank: Nadofaragene firadenovec (DB17381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 rad daily to total tumor doses of 6000-7000 rad in 6-7 weeks
Trial: 6806218
Drug: 400 rad
RxNorm normalized name: RAD-IFN
DrugBank: Nadofaragene firadenovec (DB17381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 rad daily to a total of approximately 4400 rad in 2-3 weeks
Trial: 30563042
Drug: GOX treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GOX treatments (low and high H2 O2 production rates)
Trial: 22460367
Drug: Group vocal
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group vocal improvement program (7 weekly lectures on anatomy, vocal hygiene, and vocal exercises)
Trial: 18338474
Drug: Methylergometrine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylergometrine (0.2 mg) after delivery of placenta
Trial: 10193676
Drug: Erythromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (500 mg three times a day)
Trial: 10193676
Drug: Itraconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (200 mg once a day)
Trial: 2305995
Drug: TTFCA 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA 60 mg tid (Group A)
Trial: 2305995
Drug: TTFCA 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA 30 mg tid (Group B)
Trial: 2305995
Drug: TTFCA 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA 60 mg tid (Group D, normal subjects)
Trial: 2305995
Drug: TTFCA (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTFCA (both doses in Groups A and B)
Trial: 7000223
Drug: Intramuscular cephradine
RxNorm normalized name: Cephradine
DrugBank: Cefradine (DB01333)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular cephradine 1 g 6-hourly for 48 hours
Trial: 28476133
Drug: Palatal brushing
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Palatal brushing and standard oral and denture hygiene measures
Trial: 28476133
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral and denture hygiene measures
Trial: 23786948
Drug: Structured lipid
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured lipid emulsion as parenteral alimentation
Trial: 23786948
Drug: Physically mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physically mixed medium and long‐chain fat emulsion as parenteral alimentation
Trial: 19771403
Drug: 25U BoNT/A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25U BoNT/A diluted in 2.5 ml sodium chloride solution (group I)
Trial: 19771403
Drug: 25U BoNT/A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25U BoNT/A diluted in 4 ml sodium chloride solution (group II)
Trial: 12770656
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia with hyperbaric bupivacaine 1.5 mL 0.5%
Trial: 12770656
Drug: Local infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local infiltration with a 50‐mL mixture containing 10 mL bupivacaine 0.5%, 10 mL prilocaine HCl 2%, and 30 mL isotonic solution with 1:200,000 epinephrine in combination with intravenous midazolam sedation
Trial: 8935302
Drug: Metoprolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100 mg, daily)
Trial: 8935302
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg, daily)
Trial: 8935302
Drug: Nadolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (80 mg, daily)
Trial: 29606135
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution with 20 mL/kg over 60 min at start of ERCP, followed by 3 mL/kg/h for 8 h thereafter
Trial: 29606135
Drug: No fluids
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No fluids or normal saline with a maximum of 1.5 mL/kg/h and 3 L/24 h
Trial: 26902403
Drug: Anti-resorptive (AR)
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-resorptive (AR) combination of pomegranate fruit and grape seed extracts
Trial: 26902403
Drug: Bone formation
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone formation (BF) combination of quercetin and licorice extracts
Trial: 26902403
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of all four plant extracts (AR plus BF)
Trial: 16675182
Drug: Right hip-flexed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Right hip-flexed left lateral position (L)
Trial: 8744
Drug: Physostigmine (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine (intravenous administration)
Trial: 30948503
Drug: Tangminling pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tangminling pill
Trial: 20012446
Drug: Alcohol beverage
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol beverage (1 g of ethanol per kg bodyweight; vodka and orange juice)
Trial: 15801939
Drug: Diltiazem 120
RxNorm normalized name: diltiazem 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 120 mg bid for 7 days
Trial: 12566365
Drug: Probucol 500
RxNorm normalized name: probucol 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol 500 mg BID
Trial: 12566365
Drug: AGI‐1067 70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGI‐1067 70 mg once daily
Trial: 12566365
Drug: AGI‐1067 140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGI‐1067 140 mg once daily
Trial: 12566365
Drug: AGI‐1067 280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGI‐1067 280 mg once daily
Trial: 8374931
Drug: sotalol (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotalol (320 mg/day)
Trial: 3534803
Drug: DHE 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHE 0.5 mg plus heparin 5000 U
Trial: 3534803
Drug: DHE 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHE 0.5 mg plus heparin 2500 U
Trial: 3534803
Drug: Heparin 5000
RxNorm normalized name: HEPARIN 5000 UNT/ML SYRINGE 1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin 5000 U
Trial: 3534803
Drug: DHE 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHE 0.5 mg
Trial: 27181342
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Ananas comosus extract and honey (Bromelin®)
Trial: 8101584
Drug: Morphine in
RxNorm normalized name: morphine Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine in 5% dextrose (100 micrograms/kg per h for 2 h followed by 25 micrograms/kg per h continuous infusion)
Trial: 20630656
Drug: Morphine and
RxNorm normalized name: morphine and antispasmodics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine and placebo
Trial: 2943812
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 5 micrograms of hepatitis B recombinant DNA yeast vaccine (H‐B‐VAX II) at 0 and 1 month (Group I)
Trial: 2943812
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of 5 micrograms of hepatitis B recombinant DNA yeast vaccine (H‐B‐VAX II) at 0, 1 and 6 months (Group II)
Trial: 2943812
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of 10 micrograms of plasma‐derived hepatitis B vaccine (H‐B‐VAX) (Group III)
Trial: 22587925
Drug: Heparin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin infusion at 18 U×kg(‐1)×h(‐1) for 24 hours (Group A)
Trial: 22587925
Drug: Intravenous drip
RxNorm normalized name: DRIP COLLECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous drip of 12,500 U of heparin once a day (Group B)
Trial: 22587925
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin calcium injection twice a day (Group C)
Trial: 18320208
Drug: Maltodextrin plus
RxNorm normalized name: Maltodextrin
DrugBank: Maltodextrin (DB12583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maltodextrin plus hydrolyzed whey protein enriched with 175 mg of glutamine dipeptide (MGln)
Trial: 12733728
Drug: Gross motor
RxNorm normalized name: Ostericum grosseserratum root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gross motor activities (30 minutes/day, 5 days/week for 12 months) with calcium (1000 mg/day)
Trial: 12733728
Drug: Fine motor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fine motor activities (30 minutes/day, 5 days/week for 12 months) with calcium (1000 mg/day)
Trial: 12733728
Drug: Calcium (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1000 mg/day)
Trial: 1748336
Drug: Alfentanil, up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil, up to 0.025 mg/kg
Trial: 1748336
Drug: Fentanyl, 0.0025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl, 0.0025 mg/kg
Trial: 7019841
Drug: Indomethacin treatment
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin treatment (0.2 mg/kg enteral indomethacin, three doses at eight-hour intervals in phase 2)
Trial: 7019841
Drug: Indomethacin treatment
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin treatment (0.2 mg/kg enteral indomethacin, three doses at 24-hour intervals in phase 1)
Trial: 7019841
Drug: Indomethacin treatment
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin treatment (phase 2)
Trial: 24502311
Drug: 2% methylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% methylene blue aqueous solution irradiated with light emission diode device (MBLED/PDT) with 18 J/cm(2) and placebo capsule per week
Trial: 24502311
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg oral fluconazole per week and placebo PDT (haematoxylin-diluted 1:10)
Trial: 18036291
Drug: Adenosine infusion
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine infusion (initial rate 50 microg.kg(‐1).min(‐1) increasing to 150 microg.kg(‐1).min(‐1) over 10 minutes)
Trial: 14758947
Drug: Scheduled regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheduled regimen of minor oral analgesic medications (acetaminophen [10 mg/kg] and ibuprofen [10 mg/kg] alternating every 2 hours)
Trial: 14758947
Drug: Analgesic medication
RxNorm normalized name: ANALGESIC CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic medication when requested (Control Group B)
Trial: 14758947
Drug: Scheduled regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheduled regimen of minor oral analgesic medications
Trial: 11453909
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment group (allergen‐impermeable mattress encasing, acaricide spray containing tannic acid and benzylbenzoate)
Trial: 11453909
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (allergen‐permeable encasing, spray containing water and traces of ethanol)
Trial: 8111718
Drug: DTIC 650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTIC 650 mg/m2
Trial: 8111718
Drug: DTIC 850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTIC 850 mg/m2
Trial: 8111718
Drug: DTIC (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTIC (combined low and high doses)
Trial: 3183054
Drug: Pentazocine with
RxNorm normalized name: Pentazocine
DrugBank: Pentazocine (DB00652)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentazocine with low-dose naloxone
Trial: 3183054
Drug: Morphine with
RxNorm normalized name: opium alkaloids with morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine with low-dose naloxone
Trial: 30755164
Drug: Full dose
RxNorm normalized name: BayRHo-D Full Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dose (11.4 mg betamethasone)
Trial: 30755164
Drug: Half dose
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half dose (placebo)
Trial: 28672376
Drug: Phoneme Factory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phoneme Factory Sound Sorter software administered by educators over 9 weeks
Trial: 25326216
Drug: One cycle
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One cycle treatment (group A)
Trial: 25326216
Drug: Two cycle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two cycle treatment (group B)
Trial: 24121100
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (12 weekly group sessions)
Trial: 14501608
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg E2 + 25 g SPI with 120 mg isoflavones
Trial: 14501608
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg E2 + 25 g SPI with 120 mg isoflavones
Trial: 14501608
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg E2 + placebo
Trial: 14501608
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg E2 + placebo
Trial: 3547879
Drug: Oral cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclosporine
Trial: 11103750
Drug: Bioavailability of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bioavailability of cyclosporine
Trial: 8730315
Drug: Oral artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Oral artesunate (100 mg single dose on day 1 followed by 50 mg twice daily for 5 days)
Trial: 8730315
Drug: Oral artemisinin
RxNorm normalized name: artemisinin
DrugBank: Artemisinin (DB13132)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral artemisinin (500 mg single dose on day 1 followed by 250 mg twice daily for 4 days and another 500 mg single dose on day 6)
Trial: 26688463
Drug: Oral herbs
RxNorm normalized name: Purslane Herb
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral herbs (n=35)
Trial: 26688463
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (n=32)
Trial: 26688463
Drug: Post-salvage therapy
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-salvage therapy comparison
Trial: 15892437
Drug: 3-drug regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-drug regimen of indinavir + zidovudine (or stavudine) + lamivudine
Trial: 15892437
Drug: 2-drug combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-drug combination of zidovudine (or stavudine) + lamivudine
Trial: 10562783
Drug: General anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anaesthesia with continuous epidural bupivacaine 15 mg h‐1 or bupivacaine 10 mg h‐1 with epidural morphine 0.2 mg h‐1
Trial: 8721469
Drug: DMSO 50%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMSO 50% in a fatty cream (group A)
Trial: 6841664
Drug: Loprazolam (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loprazolam (0.5, 1.0, and 1.5 mg)
Trial: 6841664
Drug: Midazolam (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (10, 20, and 30 mg)
Trial: 26189570
Drug: Intramuscular paliperidone
RxNorm normalized name: Paliperidone
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intramuscular paliperidone palmitate 3-month (PP3M) formulation (75-525 mg eq)
Trial: 26189570
Drug: Intramuscular paliperidone
RxNorm normalized name: Paliperidone
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intramuscular paliperidone immediate release (IR) (1 mg)
Trial: 24263659
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of L-carnitine (LK-3)
Trial: 24263659
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of L-carnitine (LK-4)
Trial: 16714323
Drug: Psilocybin (medium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psilocybin (medium dose: 115 microg/kg)
Trial: 16714323
Drug: Psilocybin (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psilocybin (high dose: 250 microg/kg)
Trial: 16714323
Drug: Psilocybin (medium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psilocybin (medium and high doses)
Trial: 15288990
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of droperidol and dolasetron
Trial: 7714223
Drug: MDL 11,939,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDL 11,939, 32 mg thrice daily
Trial: 2496225
Drug: Encainide during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Encainide during chronic treatment with low dose quinidine (50 mg q 6 hr)
Trial: 152681
Drug: Spironolactone, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone, 200 mg daily
Trial: 26541328
Drug: PC-enriched virgin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC-enriched virgin olive oil containing a mixture of 500 mg PC/kg from OO and thyme (FVOOT)
Trial: 26541328
Drug: PC-enriched virgin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC-enriched virgin olive oil containing 500 mg PC/kg from OO (FVOO)
Trial: 26541328
Drug: Virgin olive
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virgin olive oil naturally containing 80 mg PC/kg (VOO)
Trial: 26349830
Drug: Meropenem (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem (2 g) and RPX7009 (2 g) administered every 8 h as a 3-h intravenous infusion for a total of three doses
Trial: 16758046
Drug: Terazosin 10
RxNorm normalized name: terazosin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin 10 mg daily and analgesic (indomethacin) for a maximum of 4 weeks
Trial: 16758046
Drug: Analgesic only
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic only (control group)
Trial: 31762185
Drug: Leopold's maneuvers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leopold's maneuvers administered in the 28th week of pregnancy and re-administered in the 32nd and 36th weeks.
Trial: 28575286
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated influenza vaccine (IIV) during pregnancy